Life Sciences

Deloitte Insights

Breaking barriers to digitalization in biopharma

The pandemic's impact on R&D and commercial operating models

Article

The future unmasked

Predicting the future of healthcare and life sciences in 2025

What does the future hold for the life sciences and healthcare industry?

What does the future hold for the life sciences and healthcare industry? Our latest predictions report looks ahead to the year 2025 to help you see what’s coming and to keep your organisation moving forward.

Perspectives

Securing trust in the global COVID-19 supply chain

From development and delivery to acceptance and administration

COVID-19 vaccines and therapeutics, and the associated medical devices and consumables, present an urgent need for a protected supply chain and a system of traceability built around globally identified products.

Perspectives

COVID-19: Orchestrating the recovery of supply chains

Recover: “The new normal” starts now

Analysis

The impact of COVID-19 on China's pharmaceuticals industry

With the breakout of COVID-19, Deloitte China Life Sciences & Health Care Industry team initiated a survey to understand the virus impact on China pharmaceutical industry and measure the longer-term impact this could eventually have on their business model and operating processes.

Article

Ten years on

Measuring the return from pharmaceutical innovation 2019

Perspectives

The future of health

How innovation will blur traditional health care boundaries

Article

Harnessing opportunities and managing risk in the future of health

Article

The future of work

How can health systems and health plans prepare and transform their workforce?

The health care industry should find ways to be dynamic yet steady as younger generations enter the workforce, open talent models change how and where work happens, and disruptive technologies transform processes and consumer demands.